No Data
The Past Three Years for Jazz Pharmaceuticals (NASDAQ:JAZZ) Investors Has Not Been Profitable
Zymeworks Drops as Wells Fargo Cuts on Valuation
Earnings Preview: JAZZ to Report Financial Results Post-market on November 06
$Jazz Pharmaceuticals(JAZZ.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Jazz Pharmaceuticals(JAZZ.US)$ to post revenue of USD1.0
Jazz Pharmaceuticals Presents New Data At Psych Congress 2024 Confirming Xywav Oral Solution Treatment Benefits In Narcolepsy And Idiopathic Hypersomnia
Express News | Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia
Avadel Pharma: District Ruled in Favor of FDA in Suit Brought by Jazz Pharmaceuticals >AVDL
No Data
No Data